Advanced Search

Home > Journals > Minerva Biotecnologica > Past Issues > Minerva Biotecnologica 2008 December;20(4) > Minerva Biotecnologica 2008 December;20(4):175-81

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEMINERVA BIOTECNOLOGICA

A Journal on Biotechnology and Molecular Biology

Indexed/Abstracted in: EMBASE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,246

Frequency: Quarterly

ISSN 1120-4826

Online ISSN 1827-160X

 

Minerva Biotecnologica 2008 December;20(4):175-81

New trends in chemistry and biotechnology of peptide nucleic acidS 

PNA-mediated alteration of mRNA splicing

Breveglieri G. 1, Pensato S. 3, Salvatori F. 1, Saviano M. 3, Pedone C. 3,4, Romanelli A. 4, Gambari R. 1,2

1 BioPharmaNet, Department of Biochemistry and Molecular Biology University of Ferrara, Ferrara, Italy
2 Laboratory for the Development of Pharmacological and Pharmacogenomic Therapy of Thalassaemia Biotechnology Center, University of Ferrara, Ferrara, Italy
3 Institute of Biostructure and BioimagingUniversity of Naples, Naples, Italy
4 School of Biotechnological Sciences University of Naples “Federico II”, Naples, Italy

PNAs are expected to be very active in altering the splicing pattern of target RNA sequences. Several reports have been published on this specific task, focused on analysis of PNA altering splicing and vehiculated with a variety of delivery systems. The conclusions, here reviewed, are that PNAs altering splicing have important biological effects. In our own laboratory, we have studied the in vitro effects of a 14-mer PNA targeting a portion of the b-globin gene intron 1, suggesting that this strategy might be of interest to counteract the excess production of b-globin. Furthermore, the data obtained on the same 14-mer PNA, conjugated to the SV40 NLS peptide (b-globin-PNA/NLS) to enhance the PNA concentration in cells, demonstrate that the NLS peptide does not interfere with inhibition of the splicing.

language: English


FULL TEXT  REPRINTS

top of page